Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 16, 2025 • 2:31 PM ET

Date/Time Source News Release
05/15/2025 08:30 AM EDT GlobeNewswire CytoDyn Releases ESMO Breast Cancer Meeting Poster
05/13/2025 08:30 AM EDT GlobeNewswire CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
05/06/2025 08:30 AM EDT GlobeNewswire CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
04/29/2025 08:30 AM EDT GlobeNewswire CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany
03/18/2025 08:30 AM EDT GlobeNewswire March 2025 Letter to Shareholders
02/24/2025 08:30 AM EST GlobeNewswire CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
02/06/2025 08:30 AM EST GlobeNewswire CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
12/17/2024 08:30 AM EST GlobeNewswire December 2024 Letter to Shareholders
11/25/2024 08:30 AM EST GlobeNewswire CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology
11/04/2024 08:30 AM EST GlobeNewswire CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial
Page

Additional News

As of June 16, 2025 • 2:31 PM ET

Date/Time Source News Release
05/13/2025 03:21 PM EDT SeekingAlpha CytoDyn's new data shows leronlimab could treat solid tumors
05/06/2025 09:06 AM EDT SeekingAlpha CytoDyn appoints Robert Hoffman as CFO
04/21/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, April 21st, 2025
04/21/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cytodyn Inc
02/24/2025 12:25 PM EST AllPennyStocks.com Micro Cap Surging On Company Developed CCR5 Antagonist Showing Promise In Patients
01/16/2025 04:31 AM EST US Earnings Reports Expected earnings - Cytodyn Inc
11/04/2024 10:22 AM EST SeekingAlpha CytoDyn Phase 2 study of leronlimab cleared by FDA
10/30/2024 11:19 AM EDT Zacks AutoNation Stock Falls 3.7% Since Q3 Earnings Miss Estimates
10/30/2024 11:15 AM EDT Zacks Penske Q3 Earnings Miss Expectations, Revenues Rise Y/Y
10/29/2024 09:54 AM EDT Zacks Lear Shares Shrink 4% Since Q3 Earnings Beat Expectations
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.